Regional Analysis
Veterinary Blood Glucose Market Regional Insights:
- North America is expected to be the largest market for veterinary blood glucose monitoring devices during the forecast period, accounting for over 41% of the market share in 2023. The growth of the market in North America is attributed to the high adoption of companion animals, advanced veterinary healthcare infrastructure, and rise in pet healthcare expenditure. For instance, on June 21, 2023, Forbes, an American business magazine company published data of pet ownership in the U.S., according to which, as of 2023, 66% of U.S. households (86.9 million homes) own a pet. That’s an increase by 56% in 2023 from 1988, pet ownership statistics show.
- The market in Europe is expected to be the second-largest market for veterinary blood glucose monitoring devices, accounting for over 24% of the market share in 2023. The growth of the market is attributed to the increasing pet adoption, rising prevalence of veterinary diseases, and growing demand for point-of-care testing.
- The market in Asia Pacific is expected to be the fastest-growing market for veterinary blood glucose monitoring devices, which is expected to exhibit a CAGR of over 22.3% during the forecast period. The growth of the market in Asia Pacific is attributed to the growing disposable income, rising awareness about animal health, and increase in pet ownership in the region.
Geographies covered:
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
U.S.: 
U.K. : 
India : 
